Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$1.75 -0.09 (-4.89%)
2/9/2010 3:59 PM

Threshold Pharmaceuticals, Inc. (THLD)

CAPS Rating:
No stars

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

THLD doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Threshold Pharmaceuticals, Inc. At A Glance

Current Price: $1.75
Last Trade Time: 2/9/2010 3:59 PM
Open: $1.84
Previous Close: $1.84
Daily Range: $1.74 - $1.84
52-Week Range: $0.83 - $3.87
Volume: 64,400
Market Cap: $58.73M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

THLD VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

Threshold Pharmaceuticals, Inc. (THLD)

Avatar Rhondalo (< 20) Submitted: 12/29/06 11:45 AM

Trials look positive for pancreatic cancer and they may resume clinical research for prostate cancer.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 4 of 4  

Recs

0

 (THLD)

Avatar polvo23 (< 20) Submitted: 2/11/07 7:51 PM : Outperform Start Price: $3.31 THLD Score: -26.19

phase 3...did all the research

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (THLD)

Avatar epocrates (< 20) Submitted: 2/02/07 10:47 AM : Underperform Start Price: $3.48 THLD Score: 28.30

Pancreatic cancer is hard to show survival. Refractory pancreatic cancer is impossible to survival.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (THLD)

Avatar Rhondalo (< 20) Submitted: 12/29/06 11:45 AM : Outperform Start Price: $3.72 THLD Score: -33.08

Trials look positive for pancreatic cancer and they may resume clinical research for prostate cancer.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (THLD)

Avatar pwlkrphllp (58.92) Submitted: 12/29/06 2:36 AM : Outperform Start Price: $4.11 THLD Score: -37.54

cancer

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 4 of 4  

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 953ms